Not available
Quote | Centene Corporation (NYSE:CNC)
Last: | $67.80 |
---|---|
Change Percent: | 2.92% |
Open: | $67.09 |
Close: | $67.80 |
High: | $68.15 |
Low: | $66.18 |
Volume: | 4,304,733 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Centene Corporation (NYSE:CNC)
2024-07-17 12:06:38 ET Elevance Health ( NYSE: ELV ) shares dropped as much as 7% in morning trade, most in a year, as the company signaled towards rising medical costs, forecasting 2024 adj profit below expectations despite a beat in second quarter results.... Read the full a...
2024-07-17 08:55:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
Message Board Posts | Centene Corporation (NYSE:CNC)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CNC News Article - Centene $CNC Pivots Trading Plans and Risk Controls | whytestocks | investorshangout | 04/24/2023 5:10:49 PM |
Canada Nickel Expands High Grade, Near Surface | Diogenes of Sinope | investorshub | 04/18/2023 11:55:15 AM |
Canada Nickel Announces New Nickel Discovery at | Diogenes of Sinope | investorshub | 04/13/2023 12:23:31 PM |
Canada's budget measures brighten funding prospects for critical | Diogenes of Sinope | investorshub | 04/09/2023 9:26:11 PM |
Canada Nickel Announces Appointment of Project Debt Advisor, | Diogenes of Sinope | investorshub | 04/06/2023 4:15:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers hea...
2024-07-11 10:15:04 ET Jefferies analyst issues BUY recommendation for CNC on July 11, 2024 08:47AM ET. The previous analyst recommendation was Buy. CNC was trading at $66.38 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...
2024-07-11 10:00:10 ET David Windley from Jefferies issued a price target of $83.00 for CNC on 2024-07-11 08:47:00. The adjusted price target was set to $83.00. At the time of the announcement, CNC was trading at $66.38. The overall price target consensus is at $93.53 wi...